Holmberg, C., Ny, L., Hieken, T. J., Block, M. S., Carr, M. J., Sondak, V. K., Örtenwall, C., Katsarelias, D., Dimitriou, F., Menzies, A. M., Saw, R. P., Rogiers, A., Straker, R. J., Karakousis, G., Applewaite, R., Pallan, L., Han, D., Vetto, J. T., Gyorki, D. E., Tie, E. N., Vitale, M. G., Ascierto, P. A., Dummer, R., Cohen, J., Hui, J. Y., Schachter, J., Asher, N., Helgadottir, H., Chai, H., Kroon, H., Coventry, B., Rothermel, L. D., Sun, J., Carlino, M. S., Duncan, Z., Broman, K., Weber, J., Lee, A. Y., Berman, R. S., Teras, J., Ollila, D. W., Long, G. V., Zager, J. S., van Akkooi, A., & Olofsson Bagge, R. (2022). the efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases – A multicenter cohort study. European journal of cancer, 169, 210–222. http://access.bl.uk/ark:/81055/vdc_100156436639.0x00002c